OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Priorities in Cardio-Oncology Basic and Translational Science
Fadi N. Salloum, Carlo G. Tocchetti, Pietro Ameri, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 6, pp. 715-731
Open Access | Times Cited: 18
Fadi N. Salloum, Carlo G. Tocchetti, Pietro Ameri, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 6, pp. 715-731
Open Access | Times Cited: 18
Showing 18 citing articles:
Cardiovascular disease and cancer: shared risk factors and mechanisms
Nicholas S. Wilcox, Uri Amit, Jacob B. Reibel, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 9, pp. 617-631
Closed Access | Times Cited: 45
Nicholas S. Wilcox, Uri Amit, Jacob B. Reibel, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 9, pp. 617-631
Closed Access | Times Cited: 45
Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score
Borja Rivero‐Santana, Jesús Saldaña García, Juan Caro‐Codón, et al.
European Heart Journal (2024)
Open Access | Times Cited: 6
Borja Rivero‐Santana, Jesús Saldaña García, Juan Caro‐Codón, et al.
European Heart Journal (2024)
Open Access | Times Cited: 6
Anthracycline Cardiotoxicity in Adult Cancer Patients
Massimiliano Camilli, Carlo M. Cipolla, Susan Dent, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 5, pp. 655-677
Open Access | Times Cited: 6
Massimiliano Camilli, Carlo M. Cipolla, Susan Dent, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 5, pp. 655-677
Open Access | Times Cited: 6
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
Caroline Schoenherr, Stefan Pietzsch, Cristina Barca, et al.
Frontiers in Molecular Medicine (2025) Vol. 4
Open Access
Caroline Schoenherr, Stefan Pietzsch, Cristina Barca, et al.
Frontiers in Molecular Medicine (2025) Vol. 4
Open Access
Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond
Massimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 3
Massimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 3
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes
Ammar Bhatti, Rushin Patel, Sourbha S. Dani, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 6, pp. 863-875
Open Access | Times Cited: 3
Ammar Bhatti, Rushin Patel, Sourbha S. Dani, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 6, pp. 863-875
Open Access | Times Cited: 3
Cardio-oncology: chances and challenges
Adriana E. Viñas-Mendieta, A. Gallardo-Grajeda, Teresa López‐Fernández
Basic Research in Cardiology (2024)
Closed Access | Times Cited: 3
Adriana E. Viñas-Mendieta, A. Gallardo-Grajeda, Teresa López‐Fernández
Basic Research in Cardiology (2024)
Closed Access | Times Cited: 3
The year in cardiovascular medicine 2023: the top 10 papers in cardio-oncology
Joerg Herrmann, Teresa López‐Fernández, Alexander R. Lyon
European Heart Journal (2024) Vol. 45, Iss. 25, pp. 2197-2200
Open Access | Times Cited: 2
Joerg Herrmann, Teresa López‐Fernández, Alexander R. Lyon
European Heart Journal (2024) Vol. 45, Iss. 25, pp. 2197-2200
Open Access | Times Cited: 2
Cancer and Heart Failure: Dangerous Liaisons
D. Bertolini, Carmine Pizzi, Erwan Donal, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 9, pp. 263-263
Open Access | Times Cited: 2
D. Bertolini, Carmine Pizzi, Erwan Donal, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 9, pp. 263-263
Open Access | Times Cited: 2
Rationale and design of RESILIENCE : A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity
Andrea Moreno‐Arciniegas, Alberto López García, Malte Kelm, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2213-2222
Open Access | Times Cited: 2
Andrea Moreno‐Arciniegas, Alberto López García, Malte Kelm, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 10, pp. 2213-2222
Open Access | Times Cited: 2
Cardioprotection strategies for anthracycline cardiotoxicity
Andrea Moreno‐Arciniegas, Laura Cádiz, Carlos Galán‐Arriola, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 2
Andrea Moreno‐Arciniegas, Laura Cádiz, Carlos Galán‐Arriola, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 2
Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: the paradigm of radiotherapy
Stella Logotheti, Athanasia Pavlopoulou, Hamid Khoshfekr Rudsari, et al.
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108670-108670
Closed Access | Times Cited: 1
Stella Logotheti, Athanasia Pavlopoulou, Hamid Khoshfekr Rudsari, et al.
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108670-108670
Closed Access | Times Cited: 1
Inflammation in cardio-oncology: beyond immunotherapies
Anne Lise Ferrara, Stefania Loffredo, Carlo G. Tocchetti
European Heart Journal (2024) Vol. 45, Iss. 25, pp. 2251-2253
Open Access | Times Cited: 1
Anne Lise Ferrara, Stefania Loffredo, Carlo G. Tocchetti
European Heart Journal (2024) Vol. 45, Iss. 25, pp. 2251-2253
Open Access | Times Cited: 1
Arrhythmias in oncological patients: a compact overview for the clinician
Konstantinos Iliodromitis, Mathias Hoiczyk, Nana‐Yaw Bimpong‐Buta, et al.
Herzschrittmachertherapie + Elektrophysiologie (2024) Vol. 35, Iss. 3, pp. 177-182
Closed Access | Times Cited: 1
Konstantinos Iliodromitis, Mathias Hoiczyk, Nana‐Yaw Bimpong‐Buta, et al.
Herzschrittmachertherapie + Elektrophysiologie (2024) Vol. 35, Iss. 3, pp. 177-182
Closed Access | Times Cited: 1
Breast cancer and cardiovascular health
Teresa López‐Fernández, Irene Marco, M.C. Aznar, et al.
European Heart Journal (2024) Vol. 45, Iss. 41, pp. 4366-4382
Closed Access | Times Cited: 1
Teresa López‐Fernández, Irene Marco, M.C. Aznar, et al.
European Heart Journal (2024) Vol. 45, Iss. 41, pp. 4366-4382
Closed Access | Times Cited: 1
Role of Cancer History in Cardiovascular Mortality among Different Age-group Patients with Differentiated Thyroid Cancer
Hongrui Qiu, Wenyi Zhou, Qizhi Huang, et al.
Journal of the Endocrine Society (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Hongrui Qiu, Wenyi Zhou, Qizhi Huang, et al.
Journal of the Endocrine Society (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
The cardio-oncologic burden of breast cancer: molecular mechanisms and importance of preclinical models
Jürgen Bräuer, M. Tumani, Norbert Frey, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 1
Jürgen Bräuer, M. Tumani, Norbert Frey, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 1
Cancer Therapy-Related Cardiac Dysfunction: Strategies for Enhancing Cardiac Recovery
Pavel Martinez‐Dominguez, Maria Jose Santa Ana-Bayona, Enrique C. Guerra, et al.
Methodist DeBakey Cardiovascular Journal (2024) Vol. 20, Iss. 4, pp. 109-112
Open Access
Pavel Martinez‐Dominguez, Maria Jose Santa Ana-Bayona, Enrique C. Guerra, et al.
Methodist DeBakey Cardiovascular Journal (2024) Vol. 20, Iss. 4, pp. 109-112
Open Access
